Agenus, Inc. (AGEN)
3.84
-0.07
(-1.79%)
USD |
NASDAQ |
May 01, 16:00
3.85
+0.01
(+0.26%)
After-Hours: 19:13
Agenus Shareholders Equity (Quarterly) : -271.11M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| The Ensign Group, Inc. | 2.232B |
| Inovio Pharmaceuticals, Inc. | 24.10M |
| Protalix Biotherapeutics, Inc. | 48.23M |
| CervoMed, Inc. | 18.22M |
| Allogene Therapeutics, Inc. | 292.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.80M |
| Total Liabilities (Quarterly) | 504.66M |
| Debt to Equity Ratio | -1.235 |
| Current Ratio | 0.4125 |
| Net Debt Paydown Yield | 15.45% |